ETC
Exchange Traded Concepts’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5K | Buy |
1,926
+150
| +8% | +$3.24K | ﹤0.01% | 1319 |
|
|
2025
Q1 | $29.5K | Buy |
+1,776
| New | +$29.5K | ﹤0.01% | 1235 |
|
|
2023
Q1 | – | Sell |
-5,240
| Closed | -$83.4K | – | 1135 |
|
|
2022
Q4 | $83.4K | Buy |
5,240
+1,303
| +33% | +$20.7K | ﹤0.01% | 781 |
|
|
2022
Q3 | $64K | Buy |
3,937
+1,228
| +45% | +$20K | ﹤0.01% | 803 |
|
|
2022
Q2 | $38K | Buy |
2,709
+2,077
| +329% | +$29.1K | ﹤0.01% | 944 |
|
|
2022
Q1 | $15K | Buy |
+632
| New | +$15K | ﹤0.01% | 1061 |
|
|
2021
Q2 | – | Sell |
-2,133
| Closed | -$55K | – | 1093 |
|
|
2021
Q1 | $55K | Sell |
2,133
-11,144
| -84% | -$287K | ﹤0.01% | 802 |
|
|
2020
Q4 | $710K | Sell |
13,277
-3,048
| -19% | -$163K | 0.03% | 279 |
|
|
2020
Q3 | $673K | Buy |
16,325
+15,596
| +2,139% | +$643K | 0.04% | 231 |
|
|
2020
Q2 | $35K | Sell |
729
-156
| -18% | -$7.49K | 0.01% | 559 |
|
|
2020
Q1 | $37K | Buy |
+885
| New | +$37K | 0.02% | 305 |
|